(Q74823218)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147048%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

The Australian Guidelines for subsidisation of pharmaceuticals: the road to cost-effective drug prescribing? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147048%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

M Johannesson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147048%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 November 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147048%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147048%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147048%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147048%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

355-362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147048%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-199202050-00003

13 November 2019

exact match

0 references

cites work

Cost-effectiveness analysis of hypertension treatment--a review of methodological issues.

1 reference

12 December 2020

The use of QALYs in health care decision making

1 reference

12 December 2020

Economic evaluation of lipid lowering — A feasibility test of the contingent valuation approach

1 reference

12 December 2020

Principles of cost-effective resource allocation in health care organizations

1 reference

12 December 2020

Quality-adjusted life years, utility theory, and healthy-years equivalents

1 reference

12 December 2020

Economic evaluation of drug therapy: a review of the contingent valuation method

1 reference

12 December 2020

Risk reduction from low osmolality contrast media. What do patients think it is worth?

1 reference

12 December 2020

Economic evaluation in health care: is there a role for cost-benefit analysis?

1 reference

12 December 2020

Cost-benefit analysis of non-pharmacological treatment of hypertension

1 reference

12 December 2020

Willingness to pay and accept risks to cure chronic disease

1 reference

12 December 2020

Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals

1 reference

12 December 2020

A health-economic comparison of diet and drug treatment in obese men with mild hypertension

1 reference

12 December 2020

The economic cost of illness revisited

1 reference

12 December 2020

Economic evaluation and the rational diffusion and use of health technology

1 reference

12 December 2020

The healthy-years equivalents: how to measure them using the standard gamble approach

1 reference

12 December 2020

Willingness to pay for publicly-provided goods. A possible measure of benefit?

1 reference

12 December 2020

Willingness to pay for antihypertensive therapy--results of a Swedish pilot study

1 reference

12 December 2020